UCPVax
- Generic Name
- UCPVax
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Associated Conditions
- -
- Associated Therapies
- -
Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-09-06
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Target Recruit Count
- 105
- Registration Number
- NCT05528952
- Locations
- 🇫🇷
CH William Morey, Chalon-sur-Saône, France
🇫🇷CH de Mulhouse, Mulhouse, France
🇫🇷CHU de Besançon, Besançon, France
Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma
- First Posted Date
- 2020-02-21
- Last Posted Date
- 2023-11-08
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Target Recruit Count
- 56
- Registration Number
- NCT04280848
- Locations
- 🇫🇷
Hôpital Saint-Louis, Paris, France
🇫🇷CHU Bordeaux, Bordeaux, France
🇫🇷CHU Besançon, Besançon, France
Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)
- First Posted Date
- 2019-05-10
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Target Recruit Count
- 47
- Registration Number
- NCT03946358
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, France
🇫🇷CHU de Besançon, Besançon, France
🇫🇷Centre Georges François Leclerc, Dijon, France
Universal Cancer Peptide-based Vaccination in Metastatic NSCLC
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2016-06-29
- Last Posted Date
- 2023-07-14
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Target Recruit Count
- 54
- Registration Number
- NCT02818426
- Locations
- 🇫🇷
Centre Hospitalier Régional Universitaire de Besançon, Besancon, France
🇫🇷Hôpitaux Universitaires de Strasbourg, Strasbourg, France
🇫🇷Centre Georges François Leclerc, Dijon, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath